The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 350:1384-1386 April 1, 2004 Number 14
NextNext

Counterfeit Drugs
Paul M. Rudolf, M.D., J.D., and Ilisa B.G. Bernstein, Pharm.D., J.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
In May 2002, thousands of vials of Procrit (epoetin) labeled as containing 40,000 units were found to contain only 2000 units, and later that year, other vials of Procrit were found to contain nothing but Miami tap water. In the spring of 2003, there were reports that some Lipitor (atorvastatin) pills tasted bitter, caused a burning sensation on the tongue, and were too large. In February 2004, several Web sites sold unsuspecting consumers contraceptive patches, under the Ortho Evra brand name, that contained no active ingredient. These incidents were determined to involve counterfeit drugs, resulted in the recall of thousands . . . [Full Text of this Article]


Source Information

From the Food and Drug Administration, Rockville, Md.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.